The use of vazobral in chronic cerebral ischemia and headache

Close metadata

Recommended articles:

Sleep disorders in patients with medication-overuse headache. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5-2):93-98

Meta-analysis of randomized controlled trials of the effectiveness of Prospekta in the treatment of vascular cognitive impairment of varying severity. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):62-69

Features of primary forms of headache in multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):70-73

Integrative assessment of the effectiveness and safety of outpatient use of Picamilon. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):119-130

Significance of immunological markers in patients with obstructive sleep apnea and comorbid pathology. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8):47-53

Clinical efficacy and safety of Picamilon in patients with progressive chronic cerebral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8):71-80

Surgical treatment of congenital and acquired internal carotid artery tortuosity in patients with ocular ischemic syndrome. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(3):272-278

Medication-overuse headache: description of patients and medications used before admission to specialized center. Russian Journal of Pain. 2024;(2):16-21

Calcitonin gene-related peptide in pathophysiology of migraine. Russian Journal of Pain. 2024;(2):56-67

Efficacy of different postural control training in elderly people with chronic cerebral ischemia. Regenerative Biotechnologies, Preventive, Digital and Predictive Medicine. 2024;(2):42-48

The authors describe manifestations of chronic cerebral ischemia (CCI) and present the cases of a combination of primary headache and CCI. Management of patients with CCI and headache and the use of vazobral and its efficacy in treatment of such patients are discussed.

Keywords:

chronic cerebral ischemia

discirculatory encephalopathy

vascular cognitive impairment

stroke prevention

primary headaches

migraine

vasobral

Authors:

Parfenov V.A.

Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova, Moskva

Pozhidaev K.A.

Sechenov First Moscow State Medical University, Moscow, Russia

List of references:

Gusev EI, Bogolepova AN. Cognitive disorders in cerebrovascular diseases. M.: MEDpress-inform; 2013. (In Russ.)
Gusev EI, Chukanova EI. Modern pathogenetic aspects of the formation of chronic cerebral ischemia. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2015;115(3):4-8. (In Russ.)
Parfenov VA, Zaharov VV, Preobrazhenskaya IS. Cognitive disorders. M.: Remedium; 2014. (In Russ.)
Parfenov VA. Dyscirculatory encephalopathy and vascular cognitive disorders. M.: IMA-PRESS; 2017. (In Russ.)
Valenzuela MJ. Cerebrovascular disease, cognitive impairment and dementia. Cerebrovascular disease and dementia. 2nd ed. Edited by O’Brien J, Ames D, Gustafson L. London; N.Y.: Martin Dunitz; 2004.
Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S. Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2011;42:2672-2713.
Sachdev P, Kalaria R, O’Brien J, Skoog I, Alladi S, Black SE, Blacker D, Blazer DG, Chen C, Chui H, Ganguli M, Jellinger K, Jeste DV, Pasquier F, Paulsen J, Prins N, Rockwood K, Roman G, Scheltens P. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord. 2014;28(3):206-218.
Samorodskaya IV, Andreev EM, Zarat’yanc OV, Kosivtsova OV, Kakorina EP. Mortality rates of the population older than 50 years from cerebrovascular diseases over a 15-year period in Russia and the United States. Nevrologiya, Nejropsihiatriya i Psihosomatika. 2017;9(1):15-24. (In Russ.)
Yaxno NN, Levin OS, Damulin IV. Comparison of clinical and MRI data with discirculatory encephalopathy. Message 2: cognitive impairment. Nevrologicheskij Zhurnal. 2001;6(3):10-19. (In Russ.)
Preobrazhenskaya IS, Yahno NN. Vascular cognitive impairment: clinical manifestations, diagnosis, treatment. Nevrologicheskij Zhurnal. 2007;12(5):45-50. (In Russ.)
Yahno NN, Zaharov VV, Lokshina AB, Koberskaya NN, Mxitaryan EA. Dementia. M.: Medpress-inform; 2011. (In Russ.)
Shmidt EV. Classification of vascular lesions of the brain and spinal cord. Zhurnal Nevropatologii i Psihiatrii im. S.S. Korsakova. 1985;85(9):1281-1288. (In Russ.)
Filatova EG, Istomina OI. Treatment of chronic daily headache. Klinicheskaya Nevrologiya. 2011;1:30-35. (In Russ.)
The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808.
Golovacheva VA, Parfenov VA, Tabeeva GR, Osipova VV, Smulevich AB, Andrushchenko AV, Golovacheva AA Optimization of management of patients with chronic daily headache. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2017;117(2):4-9. (In Russ.)
Osipova VV, Tabeeva GR. Primary headaches. Practical Guidance. M.: MIA; 2014. (In Russ.)
Peng J, Lu F, Wang Z, Zhong M, Sun L, Hu N, Liu Z, Zhang W. Excessive lowering of blood pressure is not beneficial for progression of brain white matter hyperintensive and cognitive impairment in elderly hypertensive patients: 4-year follow-up study. J Am Med Dir Assoc. 2014;15:904-910.
Bath PM, Scutt P, Blackburn DJ, Ankolekar S, Krishnan K, Ballard C, Burns A, Mant J, Passmore P, Pocock S, Reckless J, Sprigg N, Stewart R, Wardlaw JM, Ford GA; PODCAST Trial Investigators. Intensive versus guideline blood pressure and lipid lowering in patients with previous stroke: Main results from the pilot «Prevention of Decline in Cognition after Stroke Trial» (PODCAST) Randomised Controlled Trial. PLoS One. 2017;12(1):e0164608.
Spinelli C, de Caro MF, Schirosi G, Mezzapesa D, De Benedittis L, Chiapparino C, Serio G, Federico F, Nazzaro P. Impaired cognitive executive dysfunction in adult treated hypertensives with a confirmed diagnosis of poorly controlled blood pressure. Int J Med Sci. 2014;11:771-778.
Solomon A, Mangialasche F, Richard E, Andrieu S, Bennett DA, Breteler M, Fratiglioni L, Hooshmand B, Khachaturian AS, Schneider LS, Skoog I, Kivipelto M. Advances in the prevention of Alzheimer’s disease and dementia. J Intern Med. 2014;275(3):229-250.
European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack. Cerebrovasc Dis. 2008;25:457-507.
Shinohara M, Sato N, Shimamura M, Kurinami H, Hamasaki T, Chatterjee A, Rakugi H, Morishita R. Possible modification of Alzheimer’s disease by statins in midlife: interactions with genetic and non-genetic risk factors. Front Aging Neurosci. 2014;6:71.
Herrmann N, Lanctot KL, Hogan DB. Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012. Alzheimers Res Ther. 2013;5(suppl 1):5.
Olin J, Schneider L, Novit A, Luczak S. Hydergine for dementia. Cochrane Database Syst Rev. 2000;3:CD000359.
Baskys A, Hou AC. Vascular dementia: Pharmacological treatment approaches and perspectives. Clin Intervent Aging. 2007;2:327-335.
Kamchatnov PR. The results of using the drug vasobral in patients with chronic disorders of cerebral circulation. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2011;111(10):70-72. (In Russ.)
Tabeeva GR, Azimova Yu.Eh. Migraine is an emphasis on preventive treatment. Spravochnik Poliklinicheskogo Vracha. 2010;9(8):55-58 (In Russ.)

Close metadata